|
Bluestar Genomics Closes $70M Series C Funding, Expands Scientific Advisory Board
|
Additional Funding and Scientific Expertise Advance Company’s Clinical Development and Efforts Towards Commercialization SAN DIEGO--(BUSINESS WIRE)--Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approac...
Full "IntellAsia: Resources" article
|
|